Cidel Asset Management Inc. boosted its position in Johnson & Johnson (NYSE:JNJ) by 3.0% in the 3rd quarter, Holdings Channel reports. The firm owned 184,431 shares of the company’s stock after buying an additional 5,292 shares during the quarter. Johnson & Johnson accounts for approximately 1.1% of Cidel Asset Management Inc.’s portfolio, making the stock its 28th biggest position. Cidel Asset Management Inc.’s holdings in Johnson & Johnson were worth $23,978,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Harding Loevner LP bought a new stake in shares of Johnson & Johnson during the second quarter valued at approximately $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in shares of Johnson & Johnson by 29.9% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after acquiring an additional 200 shares in the last quarter. Lenox Wealth Advisors Inc. raised its stake in shares of Johnson & Johnson by 0.6% during the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after acquiring an additional 5 shares in the last quarter. IHT Wealth Management LLC raised its stake in shares of Johnson & Johnson by 46.4% during the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after acquiring an additional 3,467 shares in the last quarter. Finally, Mountain Capital Investment Advisors Inc bought a new stake in shares of Johnson & Johnson during the second quarter valued at approximately $124,000. 65.71% of the stock is owned by institutional investors and hedge funds.

Several research firms have recently weighed in on JNJ. Wells Fargo & Co reaffirmed an “outperform” rating and set a $160.00 price target (up previously from $155.00) on shares of Johnson & Johnson in a research note on Friday, January 12th. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target for the company in a research note on Thursday, January 11th. Royal Bank of Canada reaffirmed a “buy” rating on shares of Johnson & Johnson in a research note on Tuesday, January 9th. Citigroup lifted their price target on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research note on Monday, October 23rd. Finally, Zacks Investment Research downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a research note on Tuesday, December 12th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have issued a buy rating to the company. Johnson & Johnson presently has a consensus rating of “Hold” and an average target price of $145.94.

Johnson & Johnson (JNJ) opened at $147.36 on Friday. The stock has a market cap of $395,890.00, a P/E ratio of 25.58, a P/E/G ratio of 2.75 and a beta of 0.80. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32. Johnson & Johnson has a 1-year low of $110.76 and a 1-year high of $148.32.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.28%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s payout ratio is 58.33%.

COPYRIGHT VIOLATION NOTICE: “Cidel Asset Management Inc. Has $23.98 Million Holdings in Johnson & Johnson (JNJ)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.watchlistnews.com/cidel-asset-management-inc-has-23-98-million-holdings-in-johnson-johnson-jnj/1816499.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.